Tizanidine Tablet
Product Images NDC 35356-662

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 35356-662). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Tizanidinehcl2mg)

This is a warning label and prescription information for Tizanidine tablets manufactured by Dr. Reddy's Laboratories Limited in India. It includes a caution to keep the medication away from children, recommended storage temperature, dosage information, and manufacturer details.*

FDA Label Image

Image Description (Fig1)

This text shows a table that lists the concentration of Tzanidine, a medication, in plasma after different dosages of 4 mg tablets or capsules taken with or without food. The concentration values are given in ng/mL, and the time since dosing is given in hours.*

FDA Label Image

Image Description (Fig2)

The text is a graph or chart, and the has failed to recognize the labels and values present, making it not-available for generating a useful description.*

FDA Label Image

Image Description (Fig3)

This text is describing a study that evaluated the improvement in Ashworth Score, a measure of muscle spasticity, in individuals taking a medication called Zanidine. The mean dose of Zanidine administered was 28.6 mg. The study lasted for 7 weeks, with the endpoint being the end of the maintenance phase. The last observation carried forward method was used to analyze the results.*

FDA Label Image

Image Description (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.